Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Cash from Operations (2016 - 2026)

Apyx Medical filings provide 15 years of Cash from Operations readings, the most recent being 2530000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 13.86% to 2530000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 8001000.0, a 55.67% increase, with the full-year FY2025 number at 8001000.0, up 55.67% from a year prior.
  • Cash from Operations hit 2530000.0 in Q4 2025 for Apyx Medical, up from 3536000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 3696000.0 in Q3 2023 to a low of 6341000.0 in Q1 2024.
  • Median Cash from Operations over the past 5 years was 3570500.0 (2021), compared with a mean of 3101300.0.
  • Biggest five-year swings in Cash from Operations: plummeted 2216.82% in 2022 and later soared 168.96% in 2023.
  • Apyx Medical's Cash from Operations stood at 214000.0 in 2021, then plummeted by 2216.82% to 4530000.0 in 2022, then soared by 51.17% to 2212000.0 in 2023, then plummeted by 32.78% to 2937000.0 in 2024, then rose by 13.86% to 2530000.0 in 2025.
  • The last three reported values for Cash from Operations were 2530000.0 (Q4 2025), 3536000.0 (Q3 2025), and 1233000.0 (Q2 2025) per Business Quant data.